Skip to content
Open access

Status of Malaria Vaccine Introduction—Africa, 2019–2024

Sep 2026 · American Journal of Tropical Medicine and Hygiene · 0 citations · 17 references
Medicine

TL;DR

The introduction of the malaria vaccine presents an integration opportunity with preventive health services to reduce child morbidity and mortality and there are two malaria vaccines prequalified by the WHO: RTS,S/AS01 and R21/Matrix-M.

Abstract

ABSTRACT. Malaria remains the primary cause of death among children younger than 5 years old in Africa. During 2019–2023, Ghana, Kenya, and Malawi piloted introduction of the first malaria vaccine, RTS,S/AS01, through the Malaria Vaccine Implementation Program. There are two malaria vaccines prequalified by the WHO: RTS,S/AS01 and R21/Matrix-M. The vaccines are recommended for children younger than 5 years old in endemic areas, prioritizing areas of moderate to high transmission. Data on vaccine introduction and doses shipped were obtained from the WHO and the United Nations Children’s Fund. As of December 2024, 17 countries in Africa had introduced the malaria vaccine with support from Gavi, the Vaccine Alliance, and another eight countries had approval for Gavi support. During 2023–2024, a total of 13,250,098 vaccine doses were shipped to countries. The introduction of the malaria vaccine presents an integration opportunity with preventive health services to reduce child morbidity and mortality.

Read PDF

Similar papers

Open access 2026

EVALUATION OF MALARIA VACCINATION WITH RTS,S/AS01 (MOSQUIRIX™) AMONG CHILDREN ATTENDING TWO DISTRICT HOSPITALS IN THE CENTRAL REGION OF CAMEROON

Malaria is a major cause of illness and death among children under five in sub-Saharan Africa. Recent progress in vaccine development, including RTS,S/AS01 shows promise for disease control with encouraging efficacy and safety profiles. This cross-sectional study assessed malaria prevalence and vaccination coverage amo...

Nfor Omarine Nlinwe, Tingwick Junior Mbah · 0 citations
Review Aug 2026

Update on malaria vaccines deployment and challenges in the field.

BACKGROUND Malaria is a life-threatening but preventable and treatable parasitic disease which remains a serious global health challenge. To meet the World Health Organization (WHO) Global Technical Strategy for Malaria 2016-2030, that aims to achieve 90% reduction of global malaria incidence by 2030, accelerated effor...

Hamtandi Magloire Natama, T. Rouamba, S. Diallo et al. · 1 citation
Open access Sep 2026

Evaluating the Impact of the Oxford R21 Malaria Vaccine on Child Mortality in High-Burden Regions of Nigeria

Malaria remains one of the leading causes of child mortality in Nigeria, with the disease claiming the lives of hundreds of thousands of children under five each year. Despite significant advances in malaria prevention and treatment, the burden of the disease continues to be disproportionately high, particularly in hig...

Iyanuoluwapo O. Adeleye · 0 citations
Open access Aug 2026

Setting the scene for the RTS,S/AS01 malaria vaccine implementation programme in Kenya: a situational analysis of the health system, malaria burden, and immunization platform

Kenya has made notable progress in reducing malaria prevalence and improving child survival, yet the lake-endemic region continues to face high transmission and substantial malaria-related illness and death. To strengthen prevention, the RTS,S/AS01 malaria vaccine was introduced in 2019 through Kenya’s Expanded Progr...

N. Westercamp, Titus K. Kwambai, S. Akech et al. · 0 citations
Review Open access Aug 2026

Malaria Vaccine Rollout in Nigeria: Current Status and Challenges

A systematic review assessed malaria vaccine rollout in Nigeria, focusing on implementation, awareness, acceptance, willingness to pay, and health system readiness.

S. A. Oyegbade, Samson Olusola Adeboye, Gbotemi Jerry Oni et al. · 0 citations
Review Sep 2026

RTS,S/AS01 mRNA Booster Platforms for Sustaining Protective Immunity Against Plasmodium Falciparum in African Children

Malaria caused by Plasmodium falciparum remained a leading cause of morbidity and mortality among African children, with hundreds of thousands of paediatric deaths annually despite expanded control measures. The RTS,S/AS01 pre-erythrocytic vaccine had demonstrated moderate efficacy, reducing clinical malaria episodes b...

Mangen Joshua Fred · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.